Stay updated with breaking news from Captor Therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PROTACs use the natural garbage disposal machinery within cells to tag and remove problematic proteins, with potential applications ranging from cancer to pesticides.
CT-01 targets 3 well suited proteins including NEK7 with poor prognosis in key liver cancerStrong preclinical data generated with CT-02 against NEK7CT-05...
10.08.2022 - WROCŁAW, Poland, Aug. 10, 2022 (GLOBE NEWSWIRE) - Captor Therapeutics S.A. (WSE:CTX), a biopharmaceutical company dedicated to the development of Targeted Protein Degradation (TPD)-based drugs for the treatment of cancer and autoimmune diseases, ...
Data confirm strong anticancer activity of two lead compounds in CT-01 programResults support advancement of CT-01 compounds towards IND expected in late...
BioDundee 2021: Focus on Covid response by pharmaceutical sector © PA How Covid-19 brought the pharmaceutical sector together to “push the boundaries” will be discussed at this year’s BioDundee conference. Celebrating its 20 Pharma response to Covid-19 Among the six sessions packed with industry experts is a focus on the pharmaceutical supply chain and its response to the pandemic. Dave Tudor, managing director of the Medicines Manufacturing Innovation Centre (MMIC), will chair the session. He will be joined by Dr Julie Brady, business development manager for drug discovery at Universi...